catalent glp 1 Novo's deal is great for GLP-1s. But what about drug manufacturing? Novo Nordisk acquiring Catalent to
Description
Purpose Glucagon-like receptor agonists (GLP1-RAs) have raised peri-procedural concerns due to their potential to delay gastric emptying
We conducted a ...
Heres what that may mean for patients.
Were excited to partner with WTW as the sustainable weight-loss and responsible prescribing solution powering their new Rx Direct Access program for GLP-1 access and affordability
these signals are hypothesis-generating only and do not establish causality or incidence
however, the benefits of these medications come at a significant financial cost to patie
